Oklahoma CyberKnife treats several different types of malignant and benign tumors in the brain, spine, lung, liver, pancreas, prostate, kidney and eye. Lung tumors, brain tumors and prostate cancer are some of the center’s most frequently treated diseases. Oklahoma CyberKnife also has specialized expertise in the treatment of trigeminal neuralgia, a neuropathic disorder that causes intense pain in the face, forehead and jaw.
Columbus CyberKnife provides stereotactic radiosurgery using the CyberKnife system. It is a non-invasive treatment that delivers high doses of radiation to tumors from multiple angles using a robotic arm. Treatments are painless and take 30-90 minutes to complete, often requiring only 1-5 sessions to treat conditions like brain tumors, lung tumors, and more. Columbus CyberKnife is part of the US Radiosurgery network and affiliated with Mount Carmel St. Ann's Hospital.
The document provides information about Austin CyberKnife and the CyberKnife treatment process. [1] Austin CyberKnife is a department of University Medical Center Brackenridge that uses the CyberKnife system to perform stereotactic radiosurgery, a noninvasive method of treating tumors with high-dose radiation from multiple angles. [2] The CyberKnife system works using a compact linear accelerator attached to a robotic arm to move around the patient and fire radiation beams from many angles, continuously tracking and compensating for tumor or patient movement. [3] The treatment process involves imaging scans, developing a customized treatment plan, and one to five outpatient sessions where the robotic arm delivers radiation beams while tracking movements.
This document discusses prevention of osteoporosis in early menopause. It begins with definitions of early menopause including bilateral oophorectomy and premature ovarian failure. It then discusses the effects of estrogen deficiency on bone loss and how early menopause can negatively impact bone mineral density. The document notes that early menopause is associated with increased risk of fractures compared to natural menopause. Finally, it discusses approaches for preventing osteoporosis in women experiencing early menopause.
As the second-most common cancer in both men and women, lung cancer is responsible for the majority of cancer-related deaths. The American Cancer Society estimates more than 160,000 people will lose their battle with lung cancer this year, accounting for more victims than breast, prostate, colon and pancreatic cancers combined.
In recognition of National Lung Cancer Awareness Month in November, Oklahoma CyberKnife encourages local residents to take preventive steps to protect themselves and their loved ones from common and lesser-known causes of lung cancer.
Prostate cancer is among the leading causes of cancer death among American men, second only to lung cancer. Learn more about prostate cancer and how Oklahoma CyberKnife's noninvasive treatment may work for you by calling (918) 949-6676.
May marks the recognition of National Brain Tumor Awareness Month. Since its establishment in 2008, community organizations and support groups celebrate this month with increased efforts to raise awareness of brain tumors, increase funding for research and educate the public on symptoms and treatment options.
Columbus CyberKnife provides stereotactic radiosurgery using the CyberKnife system. It is a non-invasive treatment that delivers high doses of radiation to tumors from multiple angles using a robotic arm. Treatments are painless and take 30-90 minutes to complete, often requiring only 1-5 sessions to treat conditions like brain tumors, lung tumors, and more. Columbus CyberKnife is part of the US Radiosurgery network and affiliated with Mount Carmel St. Ann's Hospital.
The document provides information about Austin CyberKnife and the CyberKnife treatment process. [1] Austin CyberKnife is a department of University Medical Center Brackenridge that uses the CyberKnife system to perform stereotactic radiosurgery, a noninvasive method of treating tumors with high-dose radiation from multiple angles. [2] The CyberKnife system works using a compact linear accelerator attached to a robotic arm to move around the patient and fire radiation beams from many angles, continuously tracking and compensating for tumor or patient movement. [3] The treatment process involves imaging scans, developing a customized treatment plan, and one to five outpatient sessions where the robotic arm delivers radiation beams while tracking movements.
This document discusses prevention of osteoporosis in early menopause. It begins with definitions of early menopause including bilateral oophorectomy and premature ovarian failure. It then discusses the effects of estrogen deficiency on bone loss and how early menopause can negatively impact bone mineral density. The document notes that early menopause is associated with increased risk of fractures compared to natural menopause. Finally, it discusses approaches for preventing osteoporosis in women experiencing early menopause.
As the second-most common cancer in both men and women, lung cancer is responsible for the majority of cancer-related deaths. The American Cancer Society estimates more than 160,000 people will lose their battle with lung cancer this year, accounting for more victims than breast, prostate, colon and pancreatic cancers combined.
In recognition of National Lung Cancer Awareness Month in November, Oklahoma CyberKnife encourages local residents to take preventive steps to protect themselves and their loved ones from common and lesser-known causes of lung cancer.
Prostate cancer is among the leading causes of cancer death among American men, second only to lung cancer. Learn more about prostate cancer and how Oklahoma CyberKnife's noninvasive treatment may work for you by calling (918) 949-6676.
May marks the recognition of National Brain Tumor Awareness Month. Since its establishment in 2008, community organizations and support groups celebrate this month with increased efforts to raise awareness of brain tumors, increase funding for research and educate the public on symptoms and treatment options.
Doug Williams kept a work log from February 4th to March 10th documenting his activities as a locksmith apprentice. Over this period, he cut keys, rekeyed locks for homes and vehicles, opened cars and a safe, installed a deadbolt, and made a motorcycle key. In each entry, he noted the tasks completed and provided commentary on techniques learned or areas for improvement.
1) Gamma Knife radiosurgery is a non-invasive procedure that uses focused beams of gamma radiation to treat tumors and other brain disorders without the need for surgery.
2) The Gamma Knife machine uses 201 cobalt-60 sources arranged in a hemispherical pattern to deliver beams of radiation that converge at a focal point within the brain where the tumor is located.
3) During treatment, a stereotactic frame is attached to the patient's head to precisely position their brain at the focal point, and radiation is delivered in a single session that usually lasts 2-4 hours allowing patients to go home the same day.
CyberKnife: Radiosurgery System Introductionduttaradio
Radiation source is mounted on a precisely controlled industrial robot.
- Image guidance system(continuous tracking system)
- Eliminates the need of gating techniques and restrictive head frames
Final presentation: Gammaknife vs. Cyberknife SurgerySimren Smith
Both the GammaKnife and CyberKnife are robotic radiosurgery machines that provide painless, non-surgical treatment for benign or malignant tumors. The GammaKnife was developed in 1968 and is used to treat tumors in the brain, while the CyberKnife, developed in 1994, can treat tumors anywhere in the body without immobilizing frames. Both procedures involve delivering high doses of radiation with minimal side effects and allow patients to resume daily activities shortly after treatment.
The gamma knife is a non-invasive radiosurgical device that delivers a high dose of radiation to specific parts of the brain with pinpoint accuracy. It was developed in 1968 in Sweden as a treatment for brain disorders and has a success rate of around 75%. The gamma knife procedure involves imaging scans to map the treatment area, immobilizing the patient's head with a frame, and delivering radiation beams that intersect at the target site from 201 sources. Side effects are usually mild and patients can often return home the same day.
The document describes the CyberKnife robotic radiosurgery system. It provides sub-millimeter accuracy for treating tumors throughout the body with precise radiation beams. Key features include its robotic ability to track and correct for tumor movement during treatment in real-time without needing invasive head/body frames. It has treated over 16,000 patients worldwide for conditions like brain, lung, prostate and spine tumors.
Brain metastases are secondary tumors that develop in the brain from cancer originating elsewhere. They commonly originate from primary lung cancer, breast cancer, melanoma, and renal cell carcinoma. Treatment options include surgery, whole brain radiation therapy (WBRT), and stereotactic radiosurgery (SRS) using devices like Gamma Knife and Cyberknife. SRS allows high doses of radiation to be targeted directly at the tumor while minimizing exposure to surrounding brain tissue. It is often used for smaller, solitary brain metastases or after surgical resection and WBRT.
Cyberknife is a robotic radiosurgery system that can treat tumors anywhere in the body with sub-millimeter accuracy. It contains a linear accelerator mounted on a robotic arm that moves in six degrees of freedom to accurately deliver radiation from numerous angles. Treatment is tracked in real-time using x-ray images and the robotic arm moves to correct for any tumor motion during treatment. Cyberknife allows for both single and multiple fraction stereotactic radiosurgery treatments without the need for invasive head frames.
Illinois CyberKnife is a department of Advocate Lutheran General Hospital that provides stereotactic radiosurgery using the CyberKnife system. The CyberKnife is a robotic radiosurgery system that treats tumors noninvasively using high doses of radiation targeted precisely from multiple angles. Treatments are painless, require no anesthesia, and take 30-90 minutes to complete while continuously tracking and correcting for tumor or patient movement.
The CyberKnife Center of Chicago is located in Elmhurst, Illinois and is a service of Elmhurst Memorial Hospital. It uses the CyberKnife system to perform stereotactic radiosurgery, a noninvasive procedure, to treat tumors. The CyberKnife system is a robotic linear accelerator that moves around the patient and fires radiation beams from numerous angles to treat tumors while minimizing radiation exposure to healthy tissue.
Louisville CyberKnife is a radiosurgery service located at the James Graham Brown Cancer Center in Louisville, Kentucky. It uses the CyberKnife system to precisely deliver high doses of radiation to tumors using a robotic arm. Treatments are non-invasive, painless, and take 30-90 minutes to complete over 3-5 sessions. The center is part of a national network and works with experienced physicians to provide exceptional care for cancer patients.
CyberKnife is a robotic radiosurgery system that uses targeted radiation beams from numerous angles to treat tumors without surgery or anesthesia. It features a compact linear accelerator attached to a robotic arm that moves around the patient to continuously track and compensate for tumor movement. Treatment sessions typically last 30-90 minutes and offer greater accuracy than conventional radiation therapy in targeting tumors. The Oklahoma CyberKnife center has extensive experience treating various cancer types, including lung cancer, and their physicians have conducted research on treating trigeminal neuralgia.
The parapharyngeal space is a potential space located in the neck that contains important structures like the carotid artery and cranial nerves. Tumors in this space can be benign or malignant, with the most common types being salivary gland tumors in the prestyloid space and neurogenic tumors in the retrostyloid space. Imaging like CT and MRI are used to determine the location and characteristics of the tumor. Surgical excision is typically the primary treatment, with the surgical approach depending on factors like size and involvement of surrounding structures. Observation or radiation therapy may be options for certain patients who cannot undergo surgery.
Choroidal melanoma is more common in older white males. Risk factors include sunlight exposure and genetic factors like mutations in BAP1. Clinical features include blurred vision, photopsia, and decreased light sensitivity. Examination may reveal a dark brown or creamy colored dome shaped lesion protruding into the vitreous. Diagnosis is based on orange pigment, subretinal fluid, thickness over 2mm, and growth over time. Management involves radiotherapy, phototherapy, or surgery depending on tumor size and location. Prognosis is poorer with larger tumor size, anterior location, extrascleral extension, older age, and genetic factors like monosomy 3.
4D-IGRT involves accounting for tumor motion during radiation therapy delivery. It uses 4D computed tomography (4D CT) imaging, which captures tumor position at different respiratory phases. This allows delineation of an internal target volume (ITV) that encompasses the full range of tumor motion. Treatment can then be delivered over the entire respiratory cycle or gated to a specific phase such as end-exhalation using respiratory tracking systems. The goal is to ensure accurate radiation delivery while minimizing doses to surrounding healthy tissues.
Reno CyberKnife is a radiosurgery service located in Reno, Nevada that uses the CyberKnife system to precisely deliver high doses of radiation to tumors with minimal damage to surrounding tissue. The CyberKnife system is robotic and its arm can deliver radiation beams from many angles while continuously tracking and compensating for tumor or patient movement throughout the treatment. CyberKnife treatments typically require just one to five visits and have minimal side effects compared to conventional radiation therapy.
Retinoblastoma is a highly malignant tumor that arises from retinal cells in children. It requires inactivation of both copies of the RB1 tumor suppressor gene. Treatment depends on tumor size and extent, and may include focal treatments like thermotherapy, chemotherapy, brachytherapy or external beam radiation. For more advanced cases, enucleation is needed. Long term follow up is important to monitor for potential recurrence or secondary tumors.
Malinant Salivary Gland Tumours Dr.Shaji Thomas Additional Professor,Regional...shajithoma
This document discusses malignant salivary gland tumours. It begins by stating that tumours of the salivary glands account for 5% of head and neck cancers. The main subtypes of malignant salivary gland tumours are then described, including mucoepidermoid carcinoma, adenoid cystic carcinoma, and acinic cell carcinoma. Diagnostic studies like CT, MRI and PET scans are outlined. Treatment options for the primary tumour and neck are also discussed, including surgical resection and postoperative radiation for high-risk features. Chemotherapy has a limited role and is used primarily for palliation.
This document discusses sarcomas from a surgical perspective. It defines sarcomas as heterogeneous tumors originating from mesoderm or ectoderm. The most common sarcoma subtypes are pleomorphic sarcoma, gastrointestinal stromal tumor, liposarcoma, and leiomyosarcoma. Sarcomas most often occur in extremities, trunk, and retroperitoneum. Diagnosis involves imaging like MRI or CT along with biopsy. Treatment typically involves surgical resection with negative margins, with chemotherapy or radiation used adjuvantly depending on risk factors. Prognosis depends on factors like size, grade, and margin status.
Historically, brain tumors have been treated with neurosurgical resection and radiation therapy. Demonstration of the efficacy of chemotherapy has lagged behind that for most other types of tumors, but currently chemotherapy is being employed more frequently. Recognition of the chemo-sensitivity of many types of brain tumors, in conjunction with the still relatively guarded prognoses of many of these patients, has also logically led to exploration of the use of hematopoietic cell support as a means of increasing dose intensity.
The CyberKnife is a frameless robotic radiosurgery system used to treat both benign and malignant tumors. It was invented in the 1990s and is manufactured by Accuray. It uses a compact linear accelerator mounted on a robotic arm to deliver radiation from many angles and can track tumor motion using X-ray imaging and respiratory tracking sensors. Treatment planning involves defining target volumes and constructing a correspondence model between internal fiducial markers and external sensors to track tumor position in real-time during delivery. The CyberKnife provides an alternative to frame-based radiosurgery and can fractionate treatment over multiple days.
Doug Williams kept a work log from February 4th to March 10th documenting his activities as a locksmith apprentice. Over this period, he cut keys, rekeyed locks for homes and vehicles, opened cars and a safe, installed a deadbolt, and made a motorcycle key. In each entry, he noted the tasks completed and provided commentary on techniques learned or areas for improvement.
1) Gamma Knife radiosurgery is a non-invasive procedure that uses focused beams of gamma radiation to treat tumors and other brain disorders without the need for surgery.
2) The Gamma Knife machine uses 201 cobalt-60 sources arranged in a hemispherical pattern to deliver beams of radiation that converge at a focal point within the brain where the tumor is located.
3) During treatment, a stereotactic frame is attached to the patient's head to precisely position their brain at the focal point, and radiation is delivered in a single session that usually lasts 2-4 hours allowing patients to go home the same day.
CyberKnife: Radiosurgery System Introductionduttaradio
Radiation source is mounted on a precisely controlled industrial robot.
- Image guidance system(continuous tracking system)
- Eliminates the need of gating techniques and restrictive head frames
Final presentation: Gammaknife vs. Cyberknife SurgerySimren Smith
Both the GammaKnife and CyberKnife are robotic radiosurgery machines that provide painless, non-surgical treatment for benign or malignant tumors. The GammaKnife was developed in 1968 and is used to treat tumors in the brain, while the CyberKnife, developed in 1994, can treat tumors anywhere in the body without immobilizing frames. Both procedures involve delivering high doses of radiation with minimal side effects and allow patients to resume daily activities shortly after treatment.
The gamma knife is a non-invasive radiosurgical device that delivers a high dose of radiation to specific parts of the brain with pinpoint accuracy. It was developed in 1968 in Sweden as a treatment for brain disorders and has a success rate of around 75%. The gamma knife procedure involves imaging scans to map the treatment area, immobilizing the patient's head with a frame, and delivering radiation beams that intersect at the target site from 201 sources. Side effects are usually mild and patients can often return home the same day.
The document describes the CyberKnife robotic radiosurgery system. It provides sub-millimeter accuracy for treating tumors throughout the body with precise radiation beams. Key features include its robotic ability to track and correct for tumor movement during treatment in real-time without needing invasive head/body frames. It has treated over 16,000 patients worldwide for conditions like brain, lung, prostate and spine tumors.
Brain metastases are secondary tumors that develop in the brain from cancer originating elsewhere. They commonly originate from primary lung cancer, breast cancer, melanoma, and renal cell carcinoma. Treatment options include surgery, whole brain radiation therapy (WBRT), and stereotactic radiosurgery (SRS) using devices like Gamma Knife and Cyberknife. SRS allows high doses of radiation to be targeted directly at the tumor while minimizing exposure to surrounding brain tissue. It is often used for smaller, solitary brain metastases or after surgical resection and WBRT.
Cyberknife is a robotic radiosurgery system that can treat tumors anywhere in the body with sub-millimeter accuracy. It contains a linear accelerator mounted on a robotic arm that moves in six degrees of freedom to accurately deliver radiation from numerous angles. Treatment is tracked in real-time using x-ray images and the robotic arm moves to correct for any tumor motion during treatment. Cyberknife allows for both single and multiple fraction stereotactic radiosurgery treatments without the need for invasive head frames.
Illinois CyberKnife is a department of Advocate Lutheran General Hospital that provides stereotactic radiosurgery using the CyberKnife system. The CyberKnife is a robotic radiosurgery system that treats tumors noninvasively using high doses of radiation targeted precisely from multiple angles. Treatments are painless, require no anesthesia, and take 30-90 minutes to complete while continuously tracking and correcting for tumor or patient movement.
The CyberKnife Center of Chicago is located in Elmhurst, Illinois and is a service of Elmhurst Memorial Hospital. It uses the CyberKnife system to perform stereotactic radiosurgery, a noninvasive procedure, to treat tumors. The CyberKnife system is a robotic linear accelerator that moves around the patient and fires radiation beams from numerous angles to treat tumors while minimizing radiation exposure to healthy tissue.
Louisville CyberKnife is a radiosurgery service located at the James Graham Brown Cancer Center in Louisville, Kentucky. It uses the CyberKnife system to precisely deliver high doses of radiation to tumors using a robotic arm. Treatments are non-invasive, painless, and take 30-90 minutes to complete over 3-5 sessions. The center is part of a national network and works with experienced physicians to provide exceptional care for cancer patients.
CyberKnife is a robotic radiosurgery system that uses targeted radiation beams from numerous angles to treat tumors without surgery or anesthesia. It features a compact linear accelerator attached to a robotic arm that moves around the patient to continuously track and compensate for tumor movement. Treatment sessions typically last 30-90 minutes and offer greater accuracy than conventional radiation therapy in targeting tumors. The Oklahoma CyberKnife center has extensive experience treating various cancer types, including lung cancer, and their physicians have conducted research on treating trigeminal neuralgia.
The parapharyngeal space is a potential space located in the neck that contains important structures like the carotid artery and cranial nerves. Tumors in this space can be benign or malignant, with the most common types being salivary gland tumors in the prestyloid space and neurogenic tumors in the retrostyloid space. Imaging like CT and MRI are used to determine the location and characteristics of the tumor. Surgical excision is typically the primary treatment, with the surgical approach depending on factors like size and involvement of surrounding structures. Observation or radiation therapy may be options for certain patients who cannot undergo surgery.
Choroidal melanoma is more common in older white males. Risk factors include sunlight exposure and genetic factors like mutations in BAP1. Clinical features include blurred vision, photopsia, and decreased light sensitivity. Examination may reveal a dark brown or creamy colored dome shaped lesion protruding into the vitreous. Diagnosis is based on orange pigment, subretinal fluid, thickness over 2mm, and growth over time. Management involves radiotherapy, phototherapy, or surgery depending on tumor size and location. Prognosis is poorer with larger tumor size, anterior location, extrascleral extension, older age, and genetic factors like monosomy 3.
4D-IGRT involves accounting for tumor motion during radiation therapy delivery. It uses 4D computed tomography (4D CT) imaging, which captures tumor position at different respiratory phases. This allows delineation of an internal target volume (ITV) that encompasses the full range of tumor motion. Treatment can then be delivered over the entire respiratory cycle or gated to a specific phase such as end-exhalation using respiratory tracking systems. The goal is to ensure accurate radiation delivery while minimizing doses to surrounding healthy tissues.
Reno CyberKnife is a radiosurgery service located in Reno, Nevada that uses the CyberKnife system to precisely deliver high doses of radiation to tumors with minimal damage to surrounding tissue. The CyberKnife system is robotic and its arm can deliver radiation beams from many angles while continuously tracking and compensating for tumor or patient movement throughout the treatment. CyberKnife treatments typically require just one to five visits and have minimal side effects compared to conventional radiation therapy.
Retinoblastoma is a highly malignant tumor that arises from retinal cells in children. It requires inactivation of both copies of the RB1 tumor suppressor gene. Treatment depends on tumor size and extent, and may include focal treatments like thermotherapy, chemotherapy, brachytherapy or external beam radiation. For more advanced cases, enucleation is needed. Long term follow up is important to monitor for potential recurrence or secondary tumors.
Malinant Salivary Gland Tumours Dr.Shaji Thomas Additional Professor,Regional...shajithoma
This document discusses malignant salivary gland tumours. It begins by stating that tumours of the salivary glands account for 5% of head and neck cancers. The main subtypes of malignant salivary gland tumours are then described, including mucoepidermoid carcinoma, adenoid cystic carcinoma, and acinic cell carcinoma. Diagnostic studies like CT, MRI and PET scans are outlined. Treatment options for the primary tumour and neck are also discussed, including surgical resection and postoperative radiation for high-risk features. Chemotherapy has a limited role and is used primarily for palliation.
This document discusses sarcomas from a surgical perspective. It defines sarcomas as heterogeneous tumors originating from mesoderm or ectoderm. The most common sarcoma subtypes are pleomorphic sarcoma, gastrointestinal stromal tumor, liposarcoma, and leiomyosarcoma. Sarcomas most often occur in extremities, trunk, and retroperitoneum. Diagnosis involves imaging like MRI or CT along with biopsy. Treatment typically involves surgical resection with negative margins, with chemotherapy or radiation used adjuvantly depending on risk factors. Prognosis depends on factors like size, grade, and margin status.
Historically, brain tumors have been treated with neurosurgical resection and radiation therapy. Demonstration of the efficacy of chemotherapy has lagged behind that for most other types of tumors, but currently chemotherapy is being employed more frequently. Recognition of the chemo-sensitivity of many types of brain tumors, in conjunction with the still relatively guarded prognoses of many of these patients, has also logically led to exploration of the use of hematopoietic cell support as a means of increasing dose intensity.
The CyberKnife is a frameless robotic radiosurgery system used to treat both benign and malignant tumors. It was invented in the 1990s and is manufactured by Accuray. It uses a compact linear accelerator mounted on a robotic arm to deliver radiation from many angles and can track tumor motion using X-ray imaging and respiratory tracking sensors. Treatment planning involves defining target volumes and constructing a correspondence model between internal fiducial markers and external sensors to track tumor position in real-time during delivery. The CyberKnife provides an alternative to frame-based radiosurgery and can fractionate treatment over multiple days.
This document discusses tumours of the ear, including both benign and malignant types. It provides details on the epidemiology, risk factors, pathology, diagnosis and treatment of various tumours such as basal cell carcinoma, squamous cell carcinoma, melanoma, and others. Treatment options discussed include surgical excision with various techniques depending on tumour size and location, Mohs surgery, radiation therapy, and reconstruction after tumour removal. Staging criteria and classifications of temporal bone tumours are also presented.
1. Retroperitoneal tumors are rare and often malignant, with liposarcoma and leiomyosarcoma being the most common.
2. They typically present as large abdominal masses without symptoms until they compress nearby structures.
3. CT scan is the main imaging method used to identify the tumor type, size, and involvement of surrounding organs.
4. Surgical resection is the primary treatment when possible, though radiation and chemotherapy may be used as adjuvants or for advanced disease. Prognosis depends on tumor grade, size, and whether a complete resection can be achieved.
brain tumors - KY cancer registry.pptxssuser702574
This document discusses brain tumors, including primary brain tumors which originate in the brain and secondary brain tumors which originate elsewhere and metastasize to the brain. The most common primary brain tumors are meningioma, gliomas including glioblastoma, and pituitary adenomas. Secondary brain tumors often originate from the lungs, breast, or skin (melanoma). Treatment options include surveillance with serial MRI scans, biopsy to diagnose the tumor, surgical resection to remove as much of the tumor as possible, and radiation therapy. A team approach is needed for diagnosis and individualized treatment while maximizing quality of life.
This document summarizes key points about spinal metastasis including epidemiology, symptoms, diagnostic imaging, and treatment approaches. Spinal metastasis most commonly affects the thoracic spine and presents as back pain in 70-95% of patients. Imaging plays an important role in diagnosis, with MRI and CT being most sensitive and specific. Treatment depends on factors such as neurological involvement, tumor type, and mechanical stability, and may include radiation, surgery, chemotherapy, or bisphosphonates. The goal of treatment is pain relief and preservation of neurological function.
This document provides information on the management of oral cavity cancers. It discusses that oral cavity cancers make up approximately 30% of head and neck cancers, with 80% being tobacco related. The anatomy and subsites of the oral cavity are defined. Pre-malignant lesions that can progress to cancer are described. The pathological classifications, clinical presentation, diagnostic workup, staging, prognostic factors, and principles of treatment for squamous cell carcinoma are outlined. The document discusses the surgical management of the primary tumor and neck, including different types of neck dissections. It also covers reconstructive surgery and the applications and delivery of radiotherapy.
1) Salivary gland cancers account for 6% of head and neck cancers, with 80% originating in the parotid gland. Risk factors include smoking, radiation exposure, and certain occupations.
2) The document discusses the pathology, staging, and treatment of salivary gland cancers. Surgery is the main treatment, along with radiation for high-risk cases.
3) Outcomes depend on cancer type and stage. Follow up involves regular exams and imaging to monitor for recurrence or metastases.
The document provides information about prostate cancer and treatment options from Oklahoma CyberKnife. It discusses that a prostate cancer diagnosis can be scary and lists risk factors like age, race, and diet. It describes symptoms of early-stage prostate cancer and methods of diagnosis like PSA tests and biopsies. The document outlines CyberKnife treatment for prostate cancer, including fiducial marker implantation, treatment in a body mold over 5 sessions, and post-treatment follow up. It provides resources for the Oklahoma CyberKnife center.
Prostate cancer is one of the most common cancers in American men. The document provides key statistics about prostate cancer including that it is the second leading cause of cancer death in American men and that about 174,650 new cases are estimated to be diagnosed in 2019. Some of the risk factors for prostate cancer include being over 50 years old, having a family history of prostate cancer, eating a high red meat or high fat dairy diet, and being overweight. The document recommends steps for prostate cancer prevention such as eating a diet high in fruits and vegetables, limiting red meat and processed meat intake, getting sufficient vitamin D, and avoiding smoking and excessive alcohol.
A new CPT code was created in 2013 for Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy for thoracic lesions. treatment Opened in 2008, in partnership with Hillcrest Medical Center, Oklahoma CyberKnife specializes in stereotactic radiosurgery treatment using CyberKnife® technology.
In 2013, the American Medical Association's annual updates included a new CPT code for Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy treatment planning for thoracic lesions. The decision to create a code for physician collaboration emphasizes and supports a multidisciplinary approach to providing quality patient care. Call (918) 949-6676 to learn more about Oklahoma CyberKnife.
Oklahoma CyberKnife, a cancer treatment center located in Tulsa, Oklahoma, treated its 1,000th patient this week. Since opening in 2008, the center has provided advanced cancer treatments using CyberKnife radiosurgery and stereotactic body radiation therapy to patients throughout the Midwest from states including Missouri, Kansas, Arkansas and Oklahoma. Approximately 35% of patients traveled from outside the primary service area to receive treatment at Oklahoma CyberKnife.
Oklahoma CyberKnife Treats Increased Number of Prostate Cancer PatientsOklahoma CyberKnife
Medicare expanded coverage for prostate cancer patients to receive CyberKnife treatment, allowing more Oklahoma men access to the treatment. As a result, Oklahoma CyberKnife has treated nearly as many prostate cancer patients in the first four months of 2013 as in all of 2012. CyberKnife offers a non-surgical option for prostate cancer treatment that delivers precise radiation to tumors in five or fewer sessions with minimal side effects compared to other treatments. Clinical trials show CyberKnife is an effective method for treating prostate cancer.
A service of Hillcrest Medical Center, Oklahoma
CyberKnife treats cancers of the brain, spine,
pancreas, prostate, kidney, liver and lung. We also
treat certain other medical conditions like
trigeminal neuralgia and arteriovenous
malformations.
This document discusses treatment options for prostate cancer. It provides an overview of prostate cancer statistics and factors considered for treatment selection such as cancer stage and Gleason score. Main treatment options described include watchful waiting, surgery to remove the prostate, external beam radiation therapy, brachytherapy which implants radioactive seeds in the prostate, proton therapy which uses particle acceleration, and stereotactic body radiation therapy. Each treatment option outlines procedures, recovery times, and potential side effects.
Cancer is the second leading cause of death in the US. In 2013, there will be an estimated 1.66 million new cancer cases diagnosed in the US. Lung cancer is the leading cause of cancer deaths, while prostate cancer and breast cancer will account for the highest percentage of new cancer cases among men and women respectively. Tobacco use is responsible for at least 87% of lung cancer deaths.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
1. Oklahoma
CyberKnife
is
a
service
of
Hillcrest
Medical
Center.
6802 South Olympia Ave Suite G100 Tulsa, OK 74132 (918) 949-6676 www.oklahomack.com
2. What is CyberKnife?
The
world’s
only
robo/c
radiosurgery
system,
CyberKnife
treats
pa/ents
with
a
procedure
called
stereotac(c
radiosurgery.
Stereotac/c
radiosurgery
is
a
noninvasive
method
of
trea/ng
tumors
with
high-‐dose
radia/on
precisely
aimed
from
different
angles.
How
does
CyberKnife
work?
CyberKnife
does
not
require
surgery
and
there
is
no
cu7ng
or
anesthesia
required.
Comprised
of
a
compact
linear
accelerator
-‐
a
machine
that
generates
a
radia/on
beam
-‐
aDached
to
a
highly
maneuverable
robo/c
arm.
• The
machine’s
robo/c
arm
moves
around
you,
aiming
and
firing
targeted
radia/on
beams
from
numerous
angles.
• The
imaging
and
tracking
system
con/nually
updates
the
tumor
loca/on
throughout
the
treatment
procedure,
compensa/ng
for
pa/ent
movements
like
breathing.
• Treatment
sessions
typically
last
30-‐90
minutes.
6802 South Olympia Ave Suite G100 Tulsa, OK 74132 (918) 949-6676 www.oklahomack.com
3. 6802 South Olympia Ave Suite G100 Tulsa, OK 74132 (918) 949-6676 www.oklahomack.com
4. Why Choose CyberKnife?
CyberKnife
Conven(onal
Linac
Proton
Therapy
Stereotac(c
Radia(on
Stereotac(c
Radiosurgery
Therapy
Radiosurgery
Daily
dose
5.0-‐2.0
1.8-‐3.0
5.0-‐20
1.8-‐2.0
Gy
per
frac/on
Gy
per
frac/on
Gy
per
frac/on
Gy
per
frac/on
Number
of
3-‐5
days
6-‐7
weeks
3-‐5
days
6-‐7
weeks
treatments
Accuracy
((ssue
20-‐30
20-‐30
1.5
millimeters
1-‐5
millimeters
margin)
millimeters
millimeters
Number
of
radia(on
beams
100-‐200+
beams
2-‐7
beams
5-‐15
beams
2-‐3
beams
Con(nuous
correc(on
for
breathing
and
YES
NO
NO
NO
movement
• Treats
pa/ents
in
as
few
as
one
to
five
visits
• Reaches
most
tumors
from
virtually
unlimited
• Pain
free
and
requires
no
anesthesia
direc/ons
with
robo/c
mobility
• Minimal
side
effects
• Minimizes
radia/on
exposures
to
surrounding
• Outpa/ent
procedure
healthy
/ssue
• Constantly
corrects
for
tumor
or
pa/ent
movement
• Lesions
previously
treated
with
maximum
allowed
throughout
procedures
radia/on
doses
may
be
treated
6802 South Olympia Ave Suite G100 Tulsa, OK 74132 (918) 949-6676 www.oklahomack.com
5. What does CyberKnife treat?
• Arteriovenous
malforma/on
• Bone
metastases
• Brain
tumors
• Acous/c
neuroma
• Brain
metastases
• Gliomas
• Astrocytoma
• Glioblastoma
mul/forme
• Glioma
• oligodendroglioma
• Meningioma
• Pituitary
adenoma
• Kidney
tumors
• Liver
tumors
• Lung
tumors
• Ocular/orbital
tumors
• Prostate
cancer
• Pancrea/c
cancer
• Spinal
tumors
• Trigeminal
neuralgia
6802 South Olympia Ave Suite G100 Tulsa, OK 74132 (918) 949-6676 www.oklahomack.com
6. What is the treatment process?
Consulta/on
Meet
with
the
Create
an
individualized
Appointment
CyberKnife
team
treatment
plan
Poten/al
Tissue
Markers
Pretreatment
CT
Scan
MRI
Lab
Studies
(extracranial
tumors
or
lesions)
Procedures*
The
advanced
tracking
CyberKnife’s
system
takes
x-‐ray
CyberKnife
Technicians
help
you
onto
the
robo/c
arm
moves
around
you
firing
images
to
ensure
the
If
needed,
the
pa/ent
returns
for
Treatment
treatment
table
targeted
radia/on
beams
radia/on
beam
remains
locked
on
the
up
to
4
more
treatments.
tumor
Follow-‐up
imaging
and
physical
Follow-‐up
consulta/on
to
monitor
tumor’s
progress
*The
procedures
required
as
part
of
your
individualized
treatment
plan,
and
the
order
in
which
they
will
occur,
will
be
explained
during
your
consulta/on
visit.
6802 South Olympia Ave Suite G100 Tulsa, OK 74132 (918) 949-6676 www.oklahomack.com
7. Our Center
Opened
in
2008,
Oklahoma
CyberKnife
is
widely
known
as
a
leading
provider
of
stereotac/c
radiosurgery.
In
previous
quarters,
our
center
has
provided
the
highest
number
of
CyberKnife
lung-‐cancer
treatments
of
any
CyberKnife
center
in
the
world.
Our
team
of
physicians
has
conducted
research
on
CyberKnife’s
ability
to
alleviate
trigeminal
neuralgia
pa/ents’
pain.
Our
medical
director
is
a
na/onally
recognized
expert
on
the
treatment
of
trigeminal
neuralgia
and
has
presented
clinical
findings
at
interna/onal
oncology
conferences.
Medical
Director:
Dr.
Diane
Heaton
CyberKnife
Nurse:
Lydia
Jackson
Medical
Physicist:
Stephen
Handley
Connect
with
us
6802 South Olympia Ave Suite G100 Tulsa, OK 74132 (918) 949-6676 www.oklahomack.com
8. The US Radiosurgery Network
In
partnership
with
Hillcrest
Medical
Center,
Oklahoma
CyberKnife
is
a
US
Radiosurgery
facility.
Based
in
Nashville,
Tennessee,
US
Radiosurgery
is
a
division
of
Alliance
Oncology
and
partners
with
hospitals
and
physician
groups
around
the
U.S.
to
develop
and
operate
full-‐body
radiosurgical
centers.
Collec(vely,
the
US
Radiosurgery
network
of
centers
has
treated
thousands
of
pa(ents
since
the
opening
of
the
company’s
first
center
in
2003.
The
group
of
facili/es
is
ac/vely
engaged
in
research,
with
physicians
regularly
presen/ng
papers
and
authoring
ar/cles
related
to
the
efficacy
of
CyberKnife
treatment
for
various
types
of
tumors
and
lesions.
Tumors
of
the
lung,
brain
and
prostate,
as
well
as
certain
func/onal
disorders
such
as
trigeminal
neuralgia,
have
become
key
treatment
areas
throughout
the
network
of
centers.
6802 South Olympia Ave Suite G100 Tulsa, OK 74132 (918) 949-6676 www.oklahomack.com